Immunological Aspects of Allogeneic and Autologous Mesenchymal Stem Cell Therapies

Rapamycin and MPA, But Not CsA, Impair Human NK Cell Cytotoxicity Due to Differential Effects on NK Cell Phenotype

(2010) D. N. Eissens et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Human Bone Marrow Stromal Cells and Skin Fibroblasts Inhibit Natural Killer Cell Proliferation and Cytotoxic Activity

(2010) Amandine Pradier et al.   CELL TRANSPLANTATION

Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury

(2010) Rakhi Pal et al.   CYTOTHERAPY

Immunological Aspects of Allogeneic Mesenchymal Stem Cell Therapies

(2010) Matthew D. Griffin et al.   HUMAN GENE THERAPY

Donor-Derived Mesenchymal Stem Cells Suppress Alloreactivity of Kidney Transplant Patients

(2009) Meindert J. Crop et al.   TRANSPLANTATION

Donor-Derived Mesenchymal Stem Cells Remain Present and Functional in the Transplanted Human Heart

(2008) M. J. Hoogduijn et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model

(2008) Paolo Sbano et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY

Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice

(2008) Marina Morigi et al.   STEM CELLS

Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate

(2008) F.C. Popp et al.   TRANSPLANT IMMUNOLOGY